Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1974-04-24
1976-01-13
Drezin, Norman A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
260243R, 260248GS, 260251R, 2602565R, 260283R, 260283S, 2602948G, 260297R, 2603096, 424249, 424251, 424258, 424270, 424273, A61K 3144
Patent
active
039326446
ABSTRACT:
Heterocyclic compounds which are inhibitors of histamine activity, in particular, inhibitors of H-2 histamine receptors. A specific compound of this invention is 2-[2-(4-methyl-5-imidazolylmethylthio)ethylamino]-4-pyrimidone.
REFERENCES:
patent: 3654291 (1972-04-01), Witzel et al.
patent: 3853897 (1974-12-01), Witzel et al.
Durant Graham John
Emmett John Colin
Ganellin Charon Robin
Drezin Norman A.
Edgerton William H.
Foggio Richard D.
Keps Joan S.
Smith Kline & French Laboratories, Inc.
LandOfFree
H2 histamine receptor inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with H2 histamine receptor inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and H2 histamine receptor inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-748087